BioAtla (BCAB) was downgraded to a Hold Rating at H.C. Wainwright
BioAtla (BCAB – Research Report) received a Hold rating and price target from H.C. Wainwright analyst Arthur He CFA today. The ...
Prime Medicine, Inc. (PRME) Receives a Buy from TD Cowen
In a report released yesterday, Joseph Thome from TD Cowen maintained a Buy rating on Prime Medicine, Inc. (PRME – Research Report). The ...
ARKK's holdings ranked by SA Quant Grades
Cathie Wood's ARK Innovation ETF (ARKK) has surged to its highest trading level in more than two years this week, surpassing ...
Canada orders striking dock workers back to ports
Canada ordered striking dock workers back to the ports of Vancouver, Prince Rupert and Montreal on Tuesday to clear out more ...
Big News Network.com18h
ALT5 Sigma Reports Fiscal Financial Results for Third Quarter 2024
ALT5 Prime is an electronic over-the-counter trading platform ... The Company is working on the separation of our biotech business that will become known as 'Alyea Therapeutics.' Forward Looking ...
Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial
MRCLS had clinical responses with lete-celResults include six complete responses (6/64); twenty-one partial responses ...
Yahoo Finance5h
Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update
LOS ALTOS, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive ...
PipelineReview.com23h
Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial
DARMSTADT, Germany I 12, 2024 I Merck, a leading science and technology company, today announced that the Phase III MANEUVER trial of pimicotinib, an ...